Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satya Saxena

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Pharmacology|January 16, 2003
Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571Shailendra Kumar, Neerad Mishra, Deepak Raina, et al.
Molecular Pharmacology|May 22, 2002
Inhibition of c-Abl with STI571 attenuates stress-activated protein kinase activation and apoptosis in the cellular response to 1-beta-D-arabinofuranosylcytosineDeepak Raina, Neerad Mishra, Shailendra Kumar, et al.
The Journal of Biological Chemistry|August 24, 2006
Pyrrolidine dithiocarbamate inhibits interleukin-6 signaling through impaired STAT3 activation and association with transcriptional coactivators in hepatocytesHua-Jun He, Tie-Nian Zhu, Yi Xie, et al.
Proteome Science|March 5, 2010
Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphologyJoy G Mohanty, Hem D Shukla, Jefferey D Williamson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentPieter Jelle Visser, Pallavi Sachdev, Satya Saxena, et al.
Blood|July 12, 2003
Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistanceDharminder Chauhan, Guilan Li, Teru Hideshima, et al.
Alzheimer'S Research & Therapy|April 23, 2026
Effects of the novel phosphodiesterase 9 inhibitor irsenontrine on CSF proteomics profile in Aβ<sup>+</sup> and Aβ<sup>-</sup> dementia with Lewy bodies patientsMarlies Oosthoek, Sjors G J G In 't Veld, Lisa Vermunt, et al.
The Prostate|October 12, 2013
Evaluation of ERG responsive proteome in prostate cancerShyh-Han Tan, Bungo Furusato, Xueping Fang, et al.
Cancers|October 23, 2021
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence VariantsAmol Prakash, Lorne Taylor, Manu Varkey, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Pharmacology|January 16, 2003
Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571Shailendra Kumar, Neerad Mishra, Deepak Raina, et al.
Molecular Pharmacology|May 22, 2002
Inhibition of c-Abl with STI571 attenuates stress-activated protein kinase activation and apoptosis in the cellular response to 1-beta-D-arabinofuranosylcytosineDeepak Raina, Neerad Mishra, Shailendra Kumar, et al.
The Journal of Biological Chemistry|August 24, 2006
Pyrrolidine dithiocarbamate inhibits interleukin-6 signaling through impaired STAT3 activation and association with transcriptional coactivators in hepatocytesHua-Jun He, Tie-Nian Zhu, Yi Xie, et al.
Proteome Science|March 5, 2010
Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphologyJoy G Mohanty, Hem D Shukla, Jefferey D Williamson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentPieter Jelle Visser, Pallavi Sachdev, Satya Saxena, et al.
Blood|July 12, 2003
Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistanceDharminder Chauhan, Guilan Li, Teru Hideshima, et al.
Alzheimer'S Research & Therapy|April 23, 2026
Effects of the novel phosphodiesterase 9 inhibitor irsenontrine on CSF proteomics profile in Aβ<sup>+</sup> and Aβ<sup>-</sup> dementia with Lewy bodies patientsMarlies Oosthoek, Sjors G J G In 't Veld, Lisa Vermunt, et al.
The Prostate|October 12, 2013
Evaluation of ERG responsive proteome in prostate cancerShyh-Han Tan, Bungo Furusato, Xueping Fang, et al.
Cancers|October 23, 2021
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence VariantsAmol Prakash, Lorne Taylor, Manu Varkey, et al.
Pageof 1